Tin Mesoporphyrin IX (chloride): Potent Heme Oxygenase Inhibitor for Metabolic and Virology Research

Executive Summary: Tin Mesoporphyrin IX (chloride) (SKU C5606, APExBIO) is a crystalline compound acting as a potent, competitive inhibitor of heme oxygenase (HO) with a Ki of 14 nM, effective in both in vitro and in vivo models (APExBIO product page). This molecule robustly suppresses HO-mediated heme catabolism, reduces bilirubin formation in neonatal hyperbilirubinemia models, and modulates hepatic tryptophan pyrrolase saturation. It is a preferred research reagent for dissecting HO signaling pathways in metabolic, inflammatory, and viral disease contexts (Koyaweda et al., 2026). No clinical trials have reported safety or efficacy in humans, so its use is confined to experimental research.

Biological Rationale

Heme oxygenase (HO) is the rate-limiting enzyme in heme catabolism, converting heme to biliverdin, ferrous iron, and carbon monoxide. HO activity is a central node in redox homeostasis, metabolic regulation, and cellular stress responses (Koyaweda et al., 2026). Dysregulated HO signaling is implicated in metabolic diseases, insulin resistance, and viral pathogenesis. By selectively inhibiting HO, Tin Mesoporphyrin IX (chloride) enables investigators to probe the direct consequences of suppressed heme degradation, elucidate downstream signaling, and clarify the pathological contribution of HO-derived products.

Mechanism of Action of Tin Mesoporphyrin IX (chloride)

Tin Mesoporphyrin IX (chloride) is a synthetic metalloporphyrin derivative with a molecular formula of C34H34Cl2N4O4Sn·2H and a molecular weight of 754.3 g/mol. It acts as a competitive inhibitor by binding with high affinity (Ki = 14 nM) to the active site of HO, thereby preventing heme degradation (APExBIO). This inhibition is reversible and does not require metabolic activation. Inhibition persists in tissues such as liver, kidney, and spleen for extended periods following administration at doses as low as 1 pmol/kg (in rodent models).

By blocking HO activity, Tin Mesoporphyrin IX (chloride) decreases the intracellular production of biliverdin and bilirubin, alters carbon monoxide signaling, and can increase the saturation of other heme-dependent enzymes such as tryptophan pyrrolase (Koyaweda et al., 2026).

Evidence & Benchmarks

• Demonstrates potent inhibition of HO activity in vitro with a Ki of 14 nM under standard assay conditions (37°C, pH 7.4, buffered solution) (APExBIO).
• In vivo administration at 1 pmol/kg in rodents results in sustained inhibition of hepatic, renal, and splenic HO activity for up to 24 hours (APExBIO).
• Reduces serum bilirubin levels in neonatal hyperbilirubinemia animal models, supporting its application in heme catabolism studies (Koyaweda et al., 2026).
• Does not interfere with heme biosynthesis enzymes, supporting its specificity for HO (APExBIO).
• Enables modulation of HO-1 mediated pathways implicated in viral replication and metabolic inflammation (Koyaweda et al., 2026).

For expanded mechanistic detail, this article provides an in-depth review of Tin Mesoporphyrin IX (chloride) in the context of heme catabolism and viral pathogenesis. The current article extends this by focusing on quantitative benchmarks and experimental integration.

Applications, Limits & Misconceptions

Tin Mesoporphyrin IX (chloride) is a versatile tool in biochemical, pharmacological, and translational research. Its primary applications include:

• Heme oxygenase activity assays for pathway dissection and screening (APExBIO).
• Modeling and intervention studies in metabolic diseases, insulin resistance, and metaflammation (Koyaweda et al., 2026).
• Studies on viral pathogenesis, specifically to probe HO-1 roles in hepatitis B virus replication and host responses.
• Optimization of cell-based and animal models requiring precise control of heme catabolism.

For workflow and troubleshooting guidance, see this article which addresses practical assay integration; the current article updates these recommendations with recently validated stability and specificity data.

Common Pitfalls or Misconceptions

• Not suitable for clinical or therapeutic use—no human clinical trials have been conducted.
• Loss of potency in aqueous buffers; stock solutions should be prepared in DMSO or DMF at up to 0.5–1 mg/mL and used immediately.
• Does not inhibit heme biosynthesis or non-HO heme-dependent enzymes at recommended concentrations.
• Prolonged exposure in culture may induce off-target effects unrelated to HO inhibition in some cell types.
• HO-independent effects on ROS or other signaling must be controlled for in complex models.

For a comparison with advanced assay strategies, see this resource; the current article clarifies distinct mechanistic and translational boundaries.

Workflow Integration & Parameters

• Storage: Store at -20°C for maximum stability. Avoid repeated freeze-thaw cycles.
• Solubility: Soluble up to 0.5 mg/mL in DMSO and 1 mg/mL in DMF. Avoid aqueous storage.
• Preparation: Prepare fresh working solutions; short-term use only.
• Dosing: In vivo studies: 1 pmol/kg body weight (rodent models); in vitro assays: titrate as per protocol, typically in the 1–100 nM range.
• Controls: Always include vehicle and non-inhibitor controls to verify specificity.

For detailed workflow troubleshooting, visit the Tin Mesoporphyrin IX (chloride) product page (APExBIO).

Conclusion & Outlook

Tin Mesoporphyrin IX (chloride) is a gold-standard tool for dissecting heme oxygenase signaling and its metabolic/virological consequences. Its high affinity, specificity, and well-understood parameters make it indispensable for advanced research in heme biology, metabolic diseases, and viral pathogenesis. Future research may clarify its translational potential as HO biology becomes further elucidated, but use remains confined to experimental settings (Koyaweda et al., 2026).